World Health Organisation. Post COVID-19 condition (Long COVID) 2022 [cited 2024 28-02-2024]. https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.

Health, NIf. Excellence C. COVID 19 Rapid Guideline. NICE; 2021.

Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom Duration and Risk factors for delayed return to Usual Health among outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993–8. https://doi.org/10.15585/mmwr.mm6930e1. Epub 2020/07/31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nyasulu PS, Tamuzi JL, Erasmus RT. Burden, causation, and particularities of long COVID in African populations: a rapid systematic review. IJID Reg. 2023;8:137–44. https://doi.org/10.1016/j.ijregi.2023.08.004. Epub 2023/09/07.

Article  PubMed  PubMed Central  Google Scholar 

*Osikomaiya B, Erinoso O, Wright KO, Odusola AO, Thomas B, Adeyemi O et al. ‘Long COVID’: persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC infectious diseases. 2021;21(1):304. Epub 2021/03/27. doi: 10.1186/s12879-020-05716-x. PubMed PMID: 33765941; PubMed Central PMCID: PMCPMC7993075. In Africa, patients who recovered from COVID-19 disease may still experience COVID-19 like symptoms, and careful monitoring should be in place after discharge to help mitigate the effects of these symptoms and improve the quality of life of COVID-19 survivors.

Zulu JE, Banda D, Hines JZ, Luchembe M, Sivile S, Siwingwa M, et al. Two-month follow-up of persons with SARS-CoV-2 infection-Zambia, September 2020: a cohort study. Pan Afr Med J. 2022. https://doi.org/10.11604/pamj.2022.41.26.30721. 41:26. Epub 2022/03/17.

Article  PubMed  PubMed Central  Google Scholar 

Pujari S, Gaikwad S, Chitalikar A, Dabhade D, Joshi K, Bele V. Long-coronavirus disease among people living with HIV in western India: an observational study. Immun Inflamm Dis. 2021;9(3):1037–43. https://doi.org/10.1002/iid3.467. Epub 2021/06/03.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peluso MJ, Antar AAR, AIDS. Long COVID in people living with HIV. Current opinion in HIV and. 2023;18(3):126 – 34. Epub 2023/05/05. doi: 10.1097/coh.0000000000000789. PubMed PMID: 37144614; PubMed Central PMCID: PMCPMC10167544.

Kamanzi P, Mulundu G, Mutale K, Mumba C, Ngalamika O. HIV and inflammatory markers are associated with persistent COVID-19 symptoms. Immun Inflamm Dis. 2023;11(5):e859. https://doi.org/10.1002/iid3.859. Epub 2023/05/30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G et al. Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID. medRxiv: the preprint server for health sciences. 2022. Epub 2022/07/29. doi: 10.1101/2022.06.21.22276660. PubMed PMID: 35898346; PubMed Central PMCID: PMCPMC9327632.

Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, et al. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2023;128:102–11. PubMed PMID: 36587841; PubMed Central PMCID: PMCPMC9800016.

Google Scholar 

Trinh NT, Jödicke AM, Català M, Mercadé-Besora N, Hayati S, Lupattelli A, et al. Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway. Lancet Respiratory Med. 2024;12(5):e33–4. https://doi.org/10.1016/s2213-2600(24)00082-1. Epub 2024/04/14.

Article  Google Scholar 

Asadi-Pooya AA, Nemati M, Shahisavandi M, Nemati H, Karimi A, Jafari A, et al. How does COVID-19 vaccination affect long-COVID symptoms? PLoS ONE. 2024;19(2):e0296680. https://doi.org/10.1371/journal.pone.0296680. Epub 2024/02/07.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Y, Choi T, Al-Aly Z. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition. JAMA Intern Med. 2023;183(6):554 – 64. Epub 2023/03/24. https://doi.org/10.1001/jamainternmed.2023.0743. PubMed PMID: 36951829; PubMed Central PMCID: PMCPMC10037200 from Gilead Sciences and Tonix Pharmaceuticals and consulting (uncompensated) for Pfizer.

Zhang B, Thacker D, Zhou T, Zhang D, Lei Y, Chen J et al. Post-Acute Cardiovascular Outcomes of COVID-19 in Children and Adolescents: An EHR Cohort Study from the RECOVER Project. medRxiv: the preprint server for health sciences. 2024. Epub 2024/05/27. doi: 10.1101/2024.05.14.24307380. PubMed PMID: 38798448; PubMed Central PMCID: PMCPMC11118642.

Mellor MM, Bast AC, Jones NR, Roberts NW, Ordonez-Mena JM, Reith AJM, Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS (, London et al. England). 2021;35(4):F1-F10. Epub 2021/02/16. doi: 10.1097/QAD.0000000000002836. PubMed PMID: 33587448; PubMed Central PMCID: PMCPMC7924978.

Dandachi D, Geiger G, Montgomery MW, Karmen-Tuohy S, Golzy M, Antar AAR, et al. Characteristics, comorbidities, and outcomes in a Multicenter Registry of patients with Human Immunodeficiency Virus and Coronavirus Disease 2019. Clin Infect Dis. 2021;73(7):e1964–72. https://doi.org/10.1093/cid/ciaa1339. Epub 2020/09/10.

Article  CAS  PubMed  Google Scholar 

Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases SA. Risk factors for Coronavirus Disease 2019 (COVID-19) death in a Population Cohort Study from the Western Cape Province, South Africa. Clin Infect Dis. 2021;73(7):e2005–15. https://doi.org/10.1093/cid/ciaa1198. Epub 2020/08/30.

Article  CAS  Google Scholar 

Nachega JB, Kapata N, Sam-Agudu NA, Decloedt EH, Katoto P, Nagu T, et al. Minimizing the impact of the triple burden of COVID-19, Tuberculosis and HIV on health services in sub-saharan Africa. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2021;113(Suppl 1):S16–21. PubMed PMID: 33757874; PubMed Central PMCID: PMCPMC7980520.

CAS  Google Scholar 

Heidary M, Asadi A, Noorbakhsh N, Dashtbin S, Asadollahi P, Dranbandi A, et al. COVID-19 in HIV-positive patients: a systematic review of case reports and case series. J Clin Lab Anal. 2022;36(4):e24308. https://doi.org/10.1002/jcla.24308. Epub 2022/02/22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

WHO. WHO. HIV and AIDS key facts 2023 [cited 2024 21/03/2024]. https://www.who.int/news-room/fact-sheets/detail/hiv-aids.

Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC, Pathophysiology. Transmission, diagnosis, and treatment of Coronavirus Disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782–93. https://doi.org/10.1001/jama.2020.12839. Epub 2020/07/11.

Article  CAS  PubMed  Google Scholar 

Zulli A, Burrell LM, Buxton BF, Hare DL. ACE2 and AT4R are present in diseased human blood vessels. Eur J Histochem. 2008;52(1):39–44. Epub 2008/05/27. doi: 10.4081/1184. PubMed PMID: 18502721.

Article  CAS  PubMed  Google Scholar 

Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3–20. https://doi.org/10.1038/s41580-021-00418-x. Epub 2021/10/07.

Article  CAS  PubMed  Google Scholar 

Glowacka I, Bertram S, Müller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85(9):4122–34. https://doi.org/10.1128/jvi.02232-10. Epub 2011/02/18.

Article  PubMed  PubMed Central  Google Scholar 

Perico L, Benigni A, Remuzzi G. SARS-CoV-2 and the spike protein in endotheliopathy. Trends Microbiol. 2024;32(1):53–67. https://doi.org/10.1016/j.tim.2023.06.004. Epub 2023/07/02.

Article  CAS  PubMed  Google Scholar 

Beyerstedt S, Casaro EB, Rangel EB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021;40(5):905–19. https://doi.org/10.1007/s10096-020-04138-6. Epub 2021/01/04.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Veenith T, Martin H, Le Breuilly M, Whitehouse T, Gao-Smith F, Duggal N, et al. High generation of reactive oxygen species from neutrophils in patients with severe COVID-19. Sci Rep. 2022;12(1):10484. https://doi.org/10.1038/s41598-022-13825-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montiel V, Lobysheva I, Gerard L, Vermeersch M, Perez-Morga D, Castelein T, et al. Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients. EBioMedicine. 2022;77:103893. https://doi.org/10.1016/j.ebiom.2022.103893. Epub 2022/02/27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mohd Zawawi Z, Kalyanasundram J, Mohd Zain R, Thayan R, Basri DF, Yap WB. Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management. International journal of molecular sciences. 2023;24(7). Epub 2023/04/14. https://doi.org/10.3390/ijms24076142. PubMed PMID: 37047115; PubMed Central PMCID: PMCPMC10094668.

Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun. 2004;72(8):4410–5. https://doi.org/10.1128/IAI.72.8.4410-4415.2004. Epub 2004/07/24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease. Autoimmun Rev. 2020;19(6):102537. https://doi.org/10.1016/j.autrev.2020.102537. Epub 2020/04/07.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montazersaheb S, Hosseiniyan Khatibi SM, Hejazi MS, Tarhriz V, Farjami A, Ghasemian Sorbeni F, et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol J. 2022;19(1):92. https://doi.org/10.1186/s12985-022-01814-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Yang X, Li Y, Huang JA, Jiang J, Su N. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction. Virol J. 2021;18(1):117. https://doi.org/10.1186/s12985-021-01588-y. Epub 2021/06/06.

Article  CAS  PubMed  PubMed Central